Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study
Authors:
- Jérôme FennellJFJérôme Fennell
- Akke VellingaAkke Vellinga
- Belinda HanahoeBHBelinda Hanahoe
- Dearbhaile MorrisDMDearbhaile Morris
- Fiona BoyleFBFiona Boyle
- Francis HigginsFHFrancis Higgins
- Maura LyonsMLMaura Lyons
- Karina O’connellKOKarina O’connell
- Deirbhile KeadyDKDeirbhile Keady
- Martin CormicanMCMartin Cormican
Open Access
- 15 May 2012
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 116
Abstract
Extended spectrum β-lactamase (ESBL) producing Enterobacteriaceae infections are associated with delayed initiation of appropriate treatment, poor outcomes and increased hospital stay and expense. Although initially associated with healthcare settings, more recent international reports have shown increasing isolation of ESBLs in the community. Both hospital and community ESBL epidemiology in Ireland are poorly defined.Keywords
This publication has 22 references indexed in Scilit:
- Multidrug-Resistant Gram-Negative Bacteria at a Long-Term Care Facility: Assessment of Residents, Healthcare Workers, and Inanimate SurfacesInfection Control & Hospital Epidemiology, 2009
- A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized PatientsClinical Infectious Diseases, 2009
- Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06Journal of Antimicrobial Chemotherapy, 2008
- Molecular Characterization and Epidemiology of Extended-Spectrum- β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is EndemicAntimicrobial Agents and Chemotherapy, 2008
- Clinico-epidemiological features of infections caused by CTX-M type extended spectrum beta lactamase-producing Escherichia coli in hospitalised patientsJournal of Infection, 2007
- Impact of Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella Species on Clinical Outcomes and Hospital Costs: A Matched Cohort StudyInfection Control & Hospital Epidemiology, 2006
- Bloodstream Infections Due to Extended-Spectrum β - Lactamase-Producing Escherichia coli and Klebsiella pneumoniae : Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial TherapyAntimicrobial Agents and Chemotherapy, 2004
- Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UKJournal of Antimicrobial Chemotherapy, 2004
- Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community and Private Health Care CentersAntimicrobial Agents and Chemotherapy, 2003
- A 5-year epidemiological study of extended-spectrum betabeta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unitJournal of Applied Microbiology, 2000